Description
Lecanemab is indicated for the treatment of Alzheimer’s disease in people who have mild cognitive impairment or mild dementia, but not in people who already have moderate or severe dementia.
LEQEMBI (lecanemab-irmb) injection, for intravenous use Initial U.S. Approval: 2023
See full prescribing information : Click Here
Need Help Getting Medicine? Here’s How We Can Assist You.
Brand Name “LEQEMBI” or Generic Name “lecanemab-irmb” can be imported for personal use under “Named Patient Program” treatment in Delhi, Kolkata, Surat, Jaipur, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla, Ahmedabad, Jodhpur, Mumbai, Jaipur, Aurangabad, Pune, Bangalore, Hyderabad, Chennai, Visakhapatnam, Coimbatore, Andhra Pradesh, Karnataka, Kerala, Lakshadweep, Puducherry, Tamil Nadu, Telangana, India. Contact us at support@southdelhipharma.net, southdelhipharma@gmail.com or you can call at 9891296838 or WhatsApp at 9891296838
